Search research articles
Contact Us
Filters
Showing results (741-750 of 786) with videos related to
Page
of 79
Sort By:
Journal of Clinical Medicine
|
September 4, 2020
The Impact of Obesity on the Severity of Clinicopathologic Parameters in Patients with IgA Nephropathy
Yu Ah Hong, Ji Won Min, Myung Ah Ha, et al.
BMC Geriatrics
|
December 17, 2022
Association between physical activity and risk of renal function decline and mortality in community-dwelling older adults: a nationwide population-based cohort study
Hyunsuk Kim, Mun Jung Ko, Chi-Yeon Lim, et al.
Nutrients
|
April 28, 2025
Association Between Alcohol Consumption and the Risk of Incident Chronic Kidney Disease: A Korean Nationwide Study of Community-Dwelling Older Adults
In O Sun, Hui-Seung Lee, Chiyeon Lim, et al.
International Journal of Clinical Oncology
|
January 21, 2026
Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinoma
Eiji Kikuchi, Michiel S Van der Heijden, Begoña P Valderrama, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 18, 2022
Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma
Guru P Sonpavde, Cora N Sternberg, Yohann Loriot, et al.
Brain Research
|
July 3, 2007
Human glycine alpha1 receptor inhibition by quercetin is abolished or inversed by alpha267 mutations in transmembrane domain 2
Byung-Hwan Lee, Jun-Ho Lee, In-Soo Yoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2023
A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer
David Pook, Daniel M Geynisman, Joan Carles, et al.
The Lancet. Oncology
|
October 16, 2012
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial
Yong Sang Hong, Young Suk Park, Ho Yeong Lim, et al.
Kidney Research and Clinical Practice
|
April 30, 2025
Prediction model for 6-month mortality in incident older hemodialysis patients in South Korea
Woo Yeong Park, Eunjin Bae, Hui-Seung Lee, et al.
Frontiers in Medicine
|
April 14, 2023
Dynamic nature and prognostic value of the neutrophil-to-lymphocyte ratio in critically ill patients with acute kidney injury on continuous renal replacement therapy: A multicenter cohort study
Hyun Lee Ko, Jiyun Jung, Jangwook Lee, et al.
Page
of 79
Search research articles
Search
Showing results (741-750 of 786) with videos related to
Sort By:
Page
of 79
Journal of Clinical Medicine
|
September 4, 2020
The Impact of Obesity on the Severity of Clinicopathologic Parameters in Patients with IgA Nephropathy
Yu Ah Hong, Ji Won Min, Myung Ah Ha, et al.
BMC Geriatrics
|
December 17, 2022
Association between physical activity and risk of renal function decline and mortality in community-dwelling older adults: a nationwide population-based cohort study
Hyunsuk Kim, Mun Jung Ko, Chi-Yeon Lim, et al.
Nutrients
|
April 28, 2025
Association Between Alcohol Consumption and the Risk of Incident Chronic Kidney Disease: A Korean Nationwide Study of Community-Dwelling Older Adults
In O Sun, Hui-Seung Lee, Chiyeon Lim, et al.
International Journal of Clinical Oncology
|
January 21, 2026
Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinoma
Eiji Kikuchi, Michiel S Van der Heijden, Begoña P Valderrama, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 18, 2022
Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma
Guru P Sonpavde, Cora N Sternberg, Yohann Loriot, et al.
Brain Research
|
July 3, 2007
Human glycine alpha1 receptor inhibition by quercetin is abolished or inversed by alpha267 mutations in transmembrane domain 2
Byung-Hwan Lee, Jun-Ho Lee, In-Soo Yoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2023
A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer
David Pook, Daniel M Geynisman, Joan Carles, et al.
The Lancet. Oncology
|
October 16, 2012
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial
Yong Sang Hong, Young Suk Park, Ho Yeong Lim, et al.
Kidney Research and Clinical Practice
|
April 30, 2025
Prediction model for 6-month mortality in incident older hemodialysis patients in South Korea
Woo Yeong Park, Eunjin Bae, Hui-Seung Lee, et al.
Frontiers in Medicine
|
April 14, 2023
Dynamic nature and prognostic value of the neutrophil-to-lymphocyte ratio in critically ill patients with acute kidney injury on continuous renal replacement therapy: A multicenter cohort study
Hyun Lee Ko, Jiyun Jung, Jangwook Lee, et al.
Page
of 79